XML 54 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727
SEGMENT INFORMATION
9 Months Ended
Jun. 30, 2015
SEGMENT INFORMATION [Abstract]  
SEGMENT INFORMATION
5. SEGMENT INFORMATION

 

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2014.

 

Three Months Ended
June 30,
Nine Months Ended
June 30,
 
2015 2014     2015     2014  
               
Revenue:                        
Service   $ 5,001     $ 4,754     $ 13,929     $ 14,196  
Product     1,149       1,278       3,792       3,968  
    $ 6,150     $ 6,032     $ 17,721     $ 18,164  
                                 
Operating income (loss):                                
Service   $ 1,440     $ 293     $ 1,510     $ 669  
Product     94       (37 )     194       154  
    $ 1,534     $ 256     $ 1,704     $ 823  
                                 
Interest expense     (67 )     (123 )     (223 )     (408 )
Change in fair value of warrant liability – decrease (increase)     34       66       353       (1,095 )
Other income            1       1       6  
                                 
Net income (loss) before income taxes   $ 1,501     $ 200     $ 1,835     $ (674 )